Janux Therapeutics Operating Margin Growth & History (JANX)

Janux Therapeutics's operating margin was −1,576.67% for fiscal 2025.

View full Janux Therapeutics company overview

Janux Therapeutics annual operating margin history

Janux Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−1,576.67%−643.09 pp
20242024-12-31−933.58%−30.71 pp
20232023-12-31−902.87%−123.83 pp
20222022-12-31−779.04%+126.35 pp
20212021-12-31−905.39%—

Janux Therapeutics operating margin trends

Between the periods ended 2021-12-31 and 2025-12-31, Janux Therapeutics's operating margin decreased from −905.39% to −1,576.67%, a change of −671.28 percentage points. The latest reported quarter, Q2 2026, shows −308.66%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Janux Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about JANX yet. Start the conversation.

Write the first post